TH and Parkinson disease: It has been reported that norlaudanosoline, detected in the urine of patients with Parkinson’s disease treated with L-3,4-dihydroxyphenylalanine (L-DOPA), reduces tyrosine hydroxylase activity during L-DOPA production [50,51].